nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—ABCG2—Hydrocortisone—atopic dermatitis	0.114	0.254	CbGbCtD
Leflunomide—CYP1A2—Diphenhydramine—atopic dermatitis	0.0844	0.189	CbGbCtD
Leflunomide—CYP2C9—Loratadine—atopic dermatitis	0.0761	0.17	CbGbCtD
Leflunomide—CYP2C9—Diphenhydramine—atopic dermatitis	0.0761	0.17	CbGbCtD
Leflunomide—ABCG2—Dexamethasone—atopic dermatitis	0.0708	0.158	CbGbCtD
Leflunomide—CYP2C9—Dexamethasone—atopic dermatitis	0.0263	0.0588	CbGbCtD
Leflunomide—PTK2B—Carbinoxamine—Diphenhydramine—atopic dermatitis	0.00654	1	CbGdCrCtD
Leflunomide—DHODH—Nucleotide metabolism—ADSL—atopic dermatitis	0.00493	0.107	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—RELB—atopic dermatitis	0.00237	0.0513	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—STAT6—atopic dermatitis	0.00154	0.0334	CbGpPWpGaD
Leflunomide—PTK2B—Interleukin-2 signaling—IL5—atopic dermatitis	0.00137	0.0297	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—CARD11—atopic dermatitis	0.00111	0.0239	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	0.00109	0.0237	CbGpPWpGaD
Leflunomide—PTK2B—Osteopontin-mediated events—NFKBIA—atopic dermatitis	0.00107	0.0232	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	0.000976	0.0211	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	0.000972	0.021	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—IL17A—atopic dermatitis	0.000878	0.019	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—NPS—atopic dermatitis	0.000841	0.0182	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—CASP1—atopic dermatitis	0.000745	0.0161	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	0.000708	0.0153	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	0.000708	0.0153	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL5—atopic dermatitis	0.000706	0.0153	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—PPARA—atopic dermatitis	0.000703	0.0152	CbGpPWpGaD
Leflunomide—PTK2B—Osteopontin-mediated events—MAPK8—atopic dermatitis	0.000674	0.0146	CbGpPWpGaD
Leflunomide—PTK2B—Signaling of Hepatocyte Growth Factor Receptor—MAPK8—atopic dermatitis	0.000626	0.0135	CbGpPWpGaD
Leflunomide—PTK2B—LPA receptor mediated events—NFKBIA—atopic dermatitis	0.000601	0.013	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—NFKBIA—atopic dermatitis	0.000594	0.0128	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—CD8A—atopic dermatitis	0.00059	0.0128	CbGpPWpGaD
Leflunomide—PTK2B—IL-2 Signaling Pathway—IL2—atopic dermatitis	0.000574	0.0124	CbGpPWpGaD
Leflunomide—PTK2B—Coregulation of Androgen receptor activity—CASP8—atopic dermatitis	0.000564	0.0122	CbGpPWpGaD
Leflunomide—PTK2B—Integrins in angiogenesis—CASP8—atopic dermatitis	0.000549	0.0119	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—CCR5—atopic dermatitis	0.00054	0.0117	CbGpPWpGaD
Leflunomide—PTK2B—IL2-mediated signaling events—IFNG—atopic dermatitis	0.000528	0.0114	CbGpPWpGaD
Leflunomide—PTK2B—Interleukin-2 signaling—IL2—atopic dermatitis	0.000525	0.0113	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL18—atopic dermatitis	0.000518	0.0112	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—CASP8—atopic dermatitis	0.000497	0.0108	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—PPARA—atopic dermatitis	0.000496	0.0107	CbGpPWpGaD
Leflunomide—CYP1A2—Estrogen Receptor Pathway—PPARA—atopic dermatitis	0.000488	0.0106	CbGpPWpGaD
Leflunomide—PTK2B—IL2-mediated signaling events—IL2—atopic dermatitis	0.000469	0.0102	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—GLB1—atopic dermatitis	0.000467	0.0101	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—NFKBIA—atopic dermatitis	0.000458	0.0099	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—ADSL—atopic dermatitis	0.000448	0.00968	CbGpPWpGaD
Leflunomide—PTK2B—IL2-mediated signaling events—MAPK8—atopic dermatitis	0.000432	0.00935	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CTSE—atopic dermatitis	0.00043	0.00931	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—BDNF—atopic dermatitis	0.000429	0.00929	CbGpPWpGaD
Leflunomide—PTK2B—LPA receptor mediated events—CXCL8—atopic dermatitis	0.000429	0.00928	CbGpPWpGaD
Leflunomide—PTK2B—Endothelins—MAPK8—atopic dermatitis	0.000382	0.00826	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—NGF—atopic dermatitis	0.000381	0.00824	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—MAPK8—atopic dermatitis	0.000373	0.00806	CbGpPWpGaD
Leflunomide—PTK2B—CXCR4-mediated signaling events—CD4—atopic dermatitis	0.000358	0.00775	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—CASP1—atopic dermatitis	0.000347	0.00752	CbGpPWpGaD
Leflunomide—PTK2B—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—atopic dermatitis	0.000347	0.00751	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—CD4—atopic dermatitis	0.000339	0.00733	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL5—atopic dermatitis	0.000329	0.00712	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—NFKBIA—atopic dermatitis	0.000314	0.0068	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—IL1B—atopic dermatitis	0.000313	0.00677	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—TNF—atopic dermatitis	0.000308	0.00667	CbGpPWpGaD
Leflunomide—PTK2B—Interleukin-2 signaling—IL6—atopic dermatitis	0.000308	0.00667	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000294	0.00637	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—MAPK8—atopic dermatitis	0.000287	0.00621	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—MAPK8—atopic dermatitis	0.000275	0.00595	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL1B—atopic dermatitis	0.000271	0.00585	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL2—atopic dermatitis	0.00027	0.00583	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—FCER1A—atopic dermatitis	0.000266	0.00575	CbGpPWpGaD
Leflunomide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000265	0.00573	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—IL6—atopic dermatitis	0.000249	0.00538	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—MS4A2—atopic dermatitis	0.000247	0.00535	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL18—atopic dermatitis	0.000242	0.00523	CbGpPWpGaD
Leflunomide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000226	0.0049	CbGpPWpGaD
Leflunomide—Alopecia—Dexamethasone—atopic dermatitis	0.000225	0.000451	CcSEcCtD
Leflunomide—Dizziness—Tacrolimus—atopic dermatitis	0.000225	0.00045	CcSEcCtD
Leflunomide—Hypertension—Hydrocortisone—atopic dermatitis	0.000224	0.000449	CcSEcCtD
Leflunomide—Discomfort—Prednisolone—atopic dermatitis	0.000224	0.000448	CcSEcCtD
Leflunomide—Angioedema—Triamcinolone—atopic dermatitis	0.000224	0.000447	CcSEcCtD
Leflunomide—Haemoglobin—Prednisone—atopic dermatitis	0.000223	0.000447	CcSEcCtD
Leflunomide—Angioedema—Methylprednisolone—atopic dermatitis	0.000223	0.000446	CcSEcCtD
Leflunomide—Haemorrhage—Prednisone—atopic dermatitis	0.000222	0.000445	CcSEcCtD
Leflunomide—Myalgia—Hydrocortisone—atopic dermatitis	0.000221	0.000443	CcSEcCtD
Leflunomide—Malaise—Triamcinolone—atopic dermatitis	0.000221	0.000442	CcSEcCtD
Leflunomide—Anxiety—Hydrocortisone—atopic dermatitis	0.00022	0.000441	CcSEcCtD
Leflunomide—PTK2B—Immune System—DEFB1—atopic dermatitis	0.00022	0.00476	CbGpPWpGaD
Leflunomide—Malaise—Methylprednisolone—atopic dermatitis	0.00022	0.000441	CcSEcCtD
Leflunomide—Vertigo—Triamcinolone—atopic dermatitis	0.00022	0.00044	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.00022	0.00044	CcSEcCtD
Leflunomide—Vertigo—Methylprednisolone—atopic dermatitis	0.000219	0.000439	CcSEcCtD
Leflunomide—Discomfort—Hydrocortisone—atopic dermatitis	0.000219	0.000437	CcSEcCtD
Leflunomide—Connective tissue disorder—Prednisone—atopic dermatitis	0.000218	0.000437	CcSEcCtD
Leflunomide—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000217	0.000435	CcSEcCtD
Leflunomide—Vomiting—Tacrolimus—atopic dermatitis	0.000216	0.000433	CcSEcCtD
Leflunomide—Rash—Tacrolimus—atopic dermatitis	0.000214	0.000429	CcSEcCtD
Leflunomide—Dermatitis—Tacrolimus—atopic dermatitis	0.000214	0.000429	CcSEcCtD
Leflunomide—PTK2B—Cell-Cell communication—MAPK8—atopic dermatitis	0.000214	0.00463	CbGpPWpGaD
Leflunomide—Cough—Triamcinolone—atopic dermatitis	0.000213	0.000427	CcSEcCtD
Leflunomide—Headache—Tacrolimus—atopic dermatitis	0.000213	0.000426	CcSEcCtD
Leflunomide—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000212	0.000424	CcSEcCtD
Leflunomide—Tachycardia—Prednisolone—atopic dermatitis	0.000212	0.000424	CcSEcCtD
Leflunomide—Hypertension—Triamcinolone—atopic dermatitis	0.000211	0.000423	CcSEcCtD
Leflunomide—Hypertension—Methylprednisolone—atopic dermatitis	0.000211	0.000422	CcSEcCtD
Leflunomide—Infection—Hydrocortisone—atopic dermatitis	0.000211	0.000422	CcSEcCtD
Leflunomide—Hyperhidrosis—Prednisolone—atopic dermatitis	0.00021	0.00042	CcSEcCtD
Leflunomide—Myalgia—Triamcinolone—atopic dermatitis	0.000208	0.000417	CcSEcCtD
Leflunomide—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000208	0.000416	CcSEcCtD
Leflunomide—Arthralgia—Methylprednisolone—atopic dermatitis	0.000208	0.000416	CcSEcCtD
Leflunomide—Myalgia—Methylprednisolone—atopic dermatitis	0.000208	0.000416	CcSEcCtD
Leflunomide—Eye disorder—Prednisone—atopic dermatitis	0.000208	0.000415	CcSEcCtD
Leflunomide—Anxiety—Methylprednisolone—atopic dermatitis	0.000207	0.000415	CcSEcCtD
Leflunomide—Tachycardia—Hydrocortisone—atopic dermatitis	0.000207	0.000414	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000206	0.000413	CcSEcCtD
Leflunomide—Skin disorder—Hydrocortisone—atopic dermatitis	0.000206	0.000412	CcSEcCtD
Leflunomide—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000206	0.000412	CcSEcCtD
Leflunomide—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000206	0.000412	CcSEcCtD
Leflunomide—Discomfort—Triamcinolone—atopic dermatitis	0.000206	0.000412	CcSEcCtD
Leflunomide—Discomfort—Methylprednisolone—atopic dermatitis	0.000205	0.000411	CcSEcCtD
Leflunomide—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000205	0.00041	CcSEcCtD
Leflunomide—Dry mouth—Triamcinolone—atopic dermatitis	0.000204	0.000408	CcSEcCtD
Leflunomide—Angioedema—Dexamethasone—atopic dermatitis	0.000203	0.000406	CcSEcCtD
Leflunomide—Angioedema—Betamethasone—atopic dermatitis	0.000203	0.000406	CcSEcCtD
Leflunomide—Anorexia—Hydrocortisone—atopic dermatitis	0.000202	0.000405	CcSEcCtD
Leflunomide—Nausea—Tacrolimus—atopic dermatitis	0.000202	0.000404	CcSEcCtD
Leflunomide—Immune system disorder—Prednisone—atopic dermatitis	0.000201	0.000402	CcSEcCtD
Leflunomide—Malaise—Betamethasone—atopic dermatitis	0.0002	0.000401	CcSEcCtD
Leflunomide—Malaise—Dexamethasone—atopic dermatitis	0.0002	0.000401	CcSEcCtD
Leflunomide—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.0002	0.0004	CcSEcCtD
Leflunomide—Vertigo—Dexamethasone—atopic dermatitis	0.000199	0.000399	CcSEcCtD
Leflunomide—Vertigo—Betamethasone—atopic dermatitis	0.000199	0.000399	CcSEcCtD
Leflunomide—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000199	0.000399	CcSEcCtD
Leflunomide—Arrhythmia—Prednisone—atopic dermatitis	0.000198	0.000397	CcSEcCtD
Leflunomide—Infection—Triamcinolone—atopic dermatitis	0.000198	0.000397	CcSEcCtD
Leflunomide—Hypotension—Hydrocortisone—atopic dermatitis	0.000198	0.000397	CcSEcCtD
Leflunomide—Infection—Methylprednisolone—atopic dermatitis	0.000198	0.000396	CcSEcCtD
Leflunomide—PTK2B—BDNF signaling pathway—MAPK8—atopic dermatitis	0.000197	0.00426	CbGpPWpGaD
Leflunomide—Insomnia—Prednisolone—atopic dermatitis	0.000196	0.000393	CcSEcCtD
Leflunomide—Alopecia—Prednisone—atopic dermatitis	0.000196	0.000393	CcSEcCtD
Leflunomide—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000195	0.000391	CcSEcCtD
Leflunomide—Paraesthesia—Prednisolone—atopic dermatitis	0.000195	0.00039	CcSEcCtD
Leflunomide—Tachycardia—Triamcinolone—atopic dermatitis	0.000195	0.00039	CcSEcCtD
Leflunomide—Mental disorder—Prednisone—atopic dermatitis	0.000195	0.000389	CcSEcCtD
Leflunomide—Tachycardia—Methylprednisolone—atopic dermatitis	0.000194	0.000389	CcSEcCtD
Leflunomide—Skin disorder—Methylprednisolone—atopic dermatitis	0.000193	0.000387	CcSEcCtD
Leflunomide—Malnutrition—Prednisone—atopic dermatitis	0.000193	0.000387	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000193	0.000387	CcSEcCtD
Leflunomide—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000193	0.000386	CcSEcCtD
Leflunomide—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000193	0.000386	CcSEcCtD
Leflunomide—Insomnia—Hydrocortisone—atopic dermatitis	0.000192	0.000384	CcSEcCtD
Leflunomide—Hypertension—Betamethasone—atopic dermatitis	0.000192	0.000384	CcSEcCtD
Leflunomide—Hypertension—Dexamethasone—atopic dermatitis	0.000192	0.000384	CcSEcCtD
Leflunomide—Paraesthesia—Hydrocortisone—atopic dermatitis	0.00019	0.000381	CcSEcCtD
Leflunomide—Myalgia—Betamethasone—atopic dermatitis	0.000189	0.000378	CcSEcCtD
Leflunomide—Myalgia—Dexamethasone—atopic dermatitis	0.000189	0.000378	CcSEcCtD
Leflunomide—Anxiety—Betamethasone—atopic dermatitis	0.000188	0.000377	CcSEcCtD
Leflunomide—Anxiety—Dexamethasone—atopic dermatitis	0.000188	0.000377	CcSEcCtD
Leflunomide—Discomfort—Dexamethasone—atopic dermatitis	0.000187	0.000374	CcSEcCtD
Leflunomide—Discomfort—Betamethasone—atopic dermatitis	0.000187	0.000374	CcSEcCtD
Leflunomide—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000187	0.000374	CcSEcCtD
Leflunomide—Hypotension—Methylprednisolone—atopic dermatitis	0.000186	0.000373	CcSEcCtD
Leflunomide—Pain—Prednisolone—atopic dermatitis	0.000186	0.000372	CcSEcCtD
Leflunomide—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000184	0.000369	CcSEcCtD
Leflunomide—PTK2B—TCR Signaling Pathway—IL6—atopic dermatitis	0.000183	0.00397	CbGpPWpGaD
Leflunomide—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000183	0.000366	CcSEcCtD
Leflunomide—Fatigue—Hydrocortisone—atopic dermatitis	0.000183	0.000366	CcSEcCtD
Leflunomide—Vision blurred—Prednisone—atopic dermatitis	0.000182	0.000365	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000182	0.000364	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000181	0.000363	CcSEcCtD
Leflunomide—Pain—Hydrocortisone—atopic dermatitis	0.000181	0.000363	CcSEcCtD
Leflunomide—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000181	0.000363	CcSEcCtD
Leflunomide—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000181	0.000363	CcSEcCtD
Leflunomide—Insomnia—Triamcinolone—atopic dermatitis	0.000181	0.000361	CcSEcCtD
Leflunomide—Insomnia—Methylprednisolone—atopic dermatitis	0.00018	0.000361	CcSEcCtD
Leflunomide—Infection—Dexamethasone—atopic dermatitis	0.00018	0.00036	CcSEcCtD
Leflunomide—Infection—Betamethasone—atopic dermatitis	0.00018	0.00036	CcSEcCtD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—MAPK8—atopic dermatitis	0.000179	0.00388	CbGpPWpGaD
Leflunomide—Ill-defined disorder—Prednisone—atopic dermatitis	0.000179	0.000359	CcSEcCtD
Leflunomide—Paraesthesia—Triamcinolone—atopic dermatitis	0.000179	0.000359	CcSEcCtD
Leflunomide—Feeling abnormal—Prednisolone—atopic dermatitis	0.000179	0.000358	CcSEcCtD
Leflunomide—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000179	0.000358	CcSEcCtD
Leflunomide—Anaemia—Prednisone—atopic dermatitis	0.000179	0.000358	CcSEcCtD
Leflunomide—Dyspnoea—Triamcinolone—atopic dermatitis	0.000178	0.000356	CcSEcCtD
Leflunomide—Nervous system disorder—Betamethasone—atopic dermatitis	0.000178	0.000356	CcSEcCtD
Leflunomide—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000178	0.000356	CcSEcCtD
Leflunomide—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000177	0.000355	CcSEcCtD
Leflunomide—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000177	0.000355	CcSEcCtD
Leflunomide—Tachycardia—Betamethasone—atopic dermatitis	0.000177	0.000354	CcSEcCtD
Leflunomide—Tachycardia—Dexamethasone—atopic dermatitis	0.000177	0.000354	CcSEcCtD
Leflunomide—Angioedema—Prednisone—atopic dermatitis	0.000177	0.000354	CcSEcCtD
Leflunomide—PTK2B—Immune System—KIF3A—atopic dermatitis	0.000176	0.00381	CbGpPWpGaD
Leflunomide—Dyspepsia—Triamcinolone—atopic dermatitis	0.000176	0.000352	CcSEcCtD
Leflunomide—AHR—Circadian rythm related genes—IL6—atopic dermatitis	0.000176	0.0038	CbGpPWpGaD
Leflunomide—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000175	0.000351	CcSEcCtD
Leflunomide—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000175	0.000351	CcSEcCtD
Leflunomide—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000175	0.000351	CcSEcCtD
Leflunomide—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000175	0.00035	CcSEcCtD
Leflunomide—Malaise—Prednisone—atopic dermatitis	0.000174	0.000349	CcSEcCtD
Leflunomide—Vertigo—Prednisone—atopic dermatitis	0.000174	0.000348	CcSEcCtD
Leflunomide—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000173	0.000347	CcSEcCtD
Leflunomide—Anorexia—Dexamethasone—atopic dermatitis	0.000173	0.000346	CcSEcCtD
Leflunomide—Anorexia—Betamethasone—atopic dermatitis	0.000173	0.000346	CcSEcCtD
Leflunomide—Urticaria—Prednisolone—atopic dermatitis	0.000172	0.000345	CcSEcCtD
Leflunomide—Fatigue—Triamcinolone—atopic dermatitis	0.000172	0.000345	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—FCER2—atopic dermatitis	0.000172	0.00372	CbGpPWpGaD
Leflunomide—Fatigue—Methylprednisolone—atopic dermatitis	0.000172	0.000344	CcSEcCtD
Leflunomide—Pain—Triamcinolone—atopic dermatitis	0.000171	0.000342	CcSEcCtD
Leflunomide—Hypotension—Dexamethasone—atopic dermatitis	0.000169	0.000339	CcSEcCtD
Leflunomide—Hypotension—Betamethasone—atopic dermatitis	0.000169	0.000339	CcSEcCtD
Leflunomide—Urticaria—Hydrocortisone—atopic dermatitis	0.000168	0.000337	CcSEcCtD
Leflunomide—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000168	0.000336	CcSEcCtD
Leflunomide—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000168	0.000336	CcSEcCtD
Leflunomide—Hypertension—Prednisone—atopic dermatitis	0.000167	0.000334	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000165	0.00033	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000165	0.00033	CcSEcCtD
Leflunomide—Arthralgia—Prednisone—atopic dermatitis	0.000165	0.000329	CcSEcCtD
Leflunomide—Myalgia—Prednisone—atopic dermatitis	0.000165	0.000329	CcSEcCtD
Leflunomide—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000165	0.000329	CcSEcCtD
Leflunomide—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000164	0.000329	CcSEcCtD
Leflunomide—Anxiety—Prednisone—atopic dermatitis	0.000164	0.000328	CcSEcCtD
Leflunomide—Insomnia—Dexamethasone—atopic dermatitis	0.000164	0.000328	CcSEcCtD
Leflunomide—Insomnia—Betamethasone—atopic dermatitis	0.000164	0.000328	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000163	0.000327	CcSEcCtD
Leflunomide—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000163	0.000326	CcSEcCtD
Leflunomide—Paraesthesia—Dexamethasone—atopic dermatitis	0.000163	0.000326	CcSEcCtD
Leflunomide—Paraesthesia—Betamethasone—atopic dermatitis	0.000163	0.000326	CcSEcCtD
Leflunomide—Discomfort—Prednisone—atopic dermatitis	0.000163	0.000325	CcSEcCtD
Leflunomide—Hypersensitivity—Prednisolone—atopic dermatitis	0.00016	0.00032	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—CCL22—atopic dermatitis	0.00016	0.00346	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—IL6—atopic dermatitis	0.00016	0.00345	CbGpPWpGaD
Leflunomide—Dyspepsia—Betamethasone—atopic dermatitis	0.000159	0.000319	CcSEcCtD
Leflunomide—Dyspepsia—Dexamethasone—atopic dermatitis	0.000159	0.000319	CcSEcCtD
Leflunomide—Urticaria—Triamcinolone—atopic dermatitis	0.000159	0.000318	CcSEcCtD
Leflunomide—PTK2B—Signaling by Interleukins—IL6—atopic dermatitis	0.000158	0.00343	CbGpPWpGaD
Leflunomide—Urticaria—Methylprednisolone—atopic dermatitis	0.000158	0.000317	CcSEcCtD
Leflunomide—Body temperature increased—Triamcinolone—atopic dermatitis	0.000158	0.000316	CcSEcCtD
Leflunomide—Anaphylactic shock—Prednisone—atopic dermatitis	0.000158	0.000316	CcSEcCtD
Leflunomide—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000157	0.000315	CcSEcCtD
Leflunomide—Decreased appetite—Dexamethasone—atopic dermatitis	0.000157	0.000315	CcSEcCtD
Leflunomide—Decreased appetite—Betamethasone—atopic dermatitis	0.000157	0.000315	CcSEcCtD
Leflunomide—Infection—Prednisone—atopic dermatitis	0.000157	0.000314	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000156	0.000313	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000156	0.000313	CcSEcCtD
Leflunomide—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000156	0.000313	CcSEcCtD
Leflunomide—Fatigue—Dexamethasone—atopic dermatitis	0.000156	0.000313	CcSEcCtD
Leflunomide—Fatigue—Betamethasone—atopic dermatitis	0.000156	0.000313	CcSEcCtD
Leflunomide—Pain—Dexamethasone—atopic dermatitis	0.000155	0.00031	CcSEcCtD
Leflunomide—Pain—Betamethasone—atopic dermatitis	0.000155	0.00031	CcSEcCtD
Leflunomide—Nervous system disorder—Prednisone—atopic dermatitis	0.000155	0.00031	CcSEcCtD
Leflunomide—Tachycardia—Prednisone—atopic dermatitis	0.000154	0.000308	CcSEcCtD
Leflunomide—Skin disorder—Prednisone—atopic dermatitis	0.000153	0.000307	CcSEcCtD
Leflunomide—Hyperhidrosis—Prednisone—atopic dermatitis	0.000152	0.000305	CcSEcCtD
Leflunomide—Asthenia—Hydrocortisone—atopic dermatitis	0.000152	0.000305	CcSEcCtD
Leflunomide—DHODH—Metabolism—PPARA—atopic dermatitis	0.000152	0.00328	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—IL6—atopic dermatitis	0.000151	0.00326	CbGpPWpGaD
Leflunomide—Anorexia—Prednisone—atopic dermatitis	0.00015	0.000301	CcSEcCtD
Leflunomide—Pruritus—Hydrocortisone—atopic dermatitis	0.00015	0.0003	CcSEcCtD
Leflunomide—PTK2B—Immune System—STAT6—atopic dermatitis	0.00015	0.00324	CbGpPWpGaD
Leflunomide—Feeling abnormal—Betamethasone—atopic dermatitis	0.000149	0.000299	CcSEcCtD
Leflunomide—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000149	0.000299	CcSEcCtD
Leflunomide—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000148	0.000297	CcSEcCtD
Leflunomide—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000148	0.000297	CcSEcCtD
Leflunomide—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000147	0.000294	CcSEcCtD
Leflunomide—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000147	0.000294	CcSEcCtD
Leflunomide—PTK2B—Immune System—CARD11—atopic dermatitis	0.000146	0.00315	CbGpPWpGaD
Leflunomide—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000145	0.00029	CcSEcCtD
Leflunomide—Urticaria—Dexamethasone—atopic dermatitis	0.000144	0.000288	CcSEcCtD
Leflunomide—Urticaria—Betamethasone—atopic dermatitis	0.000144	0.000288	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000144	0.000288	CcSEcCtD
Leflunomide—Dizziness—Prednisolone—atopic dermatitis	0.000144	0.000287	CcSEcCtD
Leflunomide—Asthenia—Triamcinolone—atopic dermatitis	0.000143	0.000287	CcSEcCtD
Leflunomide—Abdominal pain—Betamethasone—atopic dermatitis	0.000143	0.000287	CcSEcCtD
Leflunomide—Abdominal pain—Dexamethasone—atopic dermatitis	0.000143	0.000287	CcSEcCtD
Leflunomide—Body temperature increased—Dexamethasone—atopic dermatitis	0.000143	0.000287	CcSEcCtD
Leflunomide—Body temperature increased—Betamethasone—atopic dermatitis	0.000143	0.000287	CcSEcCtD
Leflunomide—Asthenia—Methylprednisolone—atopic dermatitis	0.000143	0.000286	CcSEcCtD
Leflunomide—Insomnia—Prednisone—atopic dermatitis	0.000143	0.000286	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—CCL27—atopic dermatitis	0.000142	0.00308	CbGpPWpGaD
Leflunomide—Paraesthesia—Prednisone—atopic dermatitis	0.000142	0.000284	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IFNG—atopic dermatitis	0.000142	0.00306	CbGpPWpGaD
Leflunomide—Pruritus—Triamcinolone—atopic dermatitis	0.000141	0.000283	CcSEcCtD
Leflunomide—Pruritus—Methylprednisolone—atopic dermatitis	0.000141	0.000282	CcSEcCtD
Leflunomide—Dizziness—Hydrocortisone—atopic dermatitis	0.00014	0.000281	CcSEcCtD
Leflunomide—Dyspepsia—Prednisone—atopic dermatitis	0.000139	0.000278	CcSEcCtD
Leflunomide—Decreased appetite—Prednisone—atopic dermatitis	0.000137	0.000275	CcSEcCtD
Leflunomide—Rash—Prednisolone—atopic dermatitis	0.000137	0.000274	CcSEcCtD
Leflunomide—Dermatitis—Prednisolone—atopic dermatitis	0.000137	0.000274	CcSEcCtD
Leflunomide—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000136	0.000273	CcSEcCtD
Leflunomide—Fatigue—Prednisone—atopic dermatitis	0.000136	0.000272	CcSEcCtD
Leflunomide—Headache—Prednisolone—atopic dermatitis	0.000136	0.000272	CcSEcCtD
Leflunomide—Constipation—Prednisone—atopic dermatitis	0.000135	0.00027	CcSEcCtD
Leflunomide—Vomiting—Hydrocortisone—atopic dermatitis	0.000135	0.00027	CcSEcCtD
Leflunomide—Rash—Hydrocortisone—atopic dermatitis	0.000134	0.000268	CcSEcCtD
Leflunomide—Dermatitis—Hydrocortisone—atopic dermatitis	0.000134	0.000267	CcSEcCtD
Leflunomide—Headache—Hydrocortisone—atopic dermatitis	0.000133	0.000266	CcSEcCtD
Leflunomide—Dizziness—Triamcinolone—atopic dermatitis	0.000132	0.000264	CcSEcCtD
Leflunomide—Dizziness—Methylprednisolone—atopic dermatitis	0.000132	0.000264	CcSEcCtD
Leflunomide—Feeling abnormal—Prednisone—atopic dermatitis	0.00013	0.00026	CcSEcCtD
Leflunomide—Asthenia—Dexamethasone—atopic dermatitis	0.00013	0.00026	CcSEcCtD
Leflunomide—Asthenia—Betamethasone—atopic dermatitis	0.00013	0.00026	CcSEcCtD
Leflunomide—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000129	0.000258	CcSEcCtD
Leflunomide—Nausea—Prednisolone—atopic dermatitis	0.000129	0.000258	CcSEcCtD
Leflunomide—Pruritus—Dexamethasone—atopic dermatitis	0.000128	0.000257	CcSEcCtD
Leflunomide—Pruritus—Betamethasone—atopic dermatitis	0.000128	0.000257	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—CCL17—atopic dermatitis	0.000128	0.00276	CbGpPWpGaD
Leflunomide—Vomiting—Triamcinolone—atopic dermatitis	0.000127	0.000254	CcSEcCtD
Leflunomide—Vomiting—Methylprednisolone—atopic dermatitis	0.000127	0.000254	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL1B—atopic dermatitis	0.000126	0.00273	CbGpPWpGaD
Leflunomide—Nausea—Hydrocortisone—atopic dermatitis	0.000126	0.000252	CcSEcCtD
Leflunomide—Rash—Triamcinolone—atopic dermatitis	0.000126	0.000252	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL2—atopic dermatitis	0.000126	0.00272	CbGpPWpGaD
Leflunomide—Dermatitis—Triamcinolone—atopic dermatitis	0.000126	0.000252	CcSEcCtD
Leflunomide—Rash—Methylprednisolone—atopic dermatitis	0.000126	0.000251	CcSEcCtD
Leflunomide—Dermatitis—Methylprednisolone—atopic dermatitis	0.000125	0.000251	CcSEcCtD
Leflunomide—Urticaria—Prednisone—atopic dermatitis	0.000125	0.000251	CcSEcCtD
Leflunomide—Headache—Triamcinolone—atopic dermatitis	0.000125	0.00025	CcSEcCtD
Leflunomide—Headache—Methylprednisolone—atopic dermatitis	0.000125	0.00025	CcSEcCtD
Leflunomide—Body temperature increased—Prednisone—atopic dermatitis	0.000125	0.00025	CcSEcCtD
Leflunomide—Abdominal pain—Prednisone—atopic dermatitis	0.000125	0.00025	CcSEcCtD
Leflunomide—Diarrhoea—Dexamethasone—atopic dermatitis	0.000124	0.000248	CcSEcCtD
Leflunomide—Diarrhoea—Betamethasone—atopic dermatitis	0.000124	0.000248	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	0.000121	0.00261	CbGpPWpGaD
Leflunomide—Dizziness—Dexamethasone—atopic dermatitis	0.00012	0.00024	CcSEcCtD
Leflunomide—Dizziness—Betamethasone—atopic dermatitis	0.00012	0.00024	CcSEcCtD
Leflunomide—Nausea—Triamcinolone—atopic dermatitis	0.000119	0.000237	CcSEcCtD
Leflunomide—Nausea—Methylprednisolone—atopic dermatitis	0.000118	0.000237	CcSEcCtD
Leflunomide—Hypersensitivity—Prednisone—atopic dermatitis	0.000116	0.000233	CcSEcCtD
Leflunomide—Vomiting—Betamethasone—atopic dermatitis	0.000115	0.000231	CcSEcCtD
Leflunomide—Vomiting—Dexamethasone—atopic dermatitis	0.000115	0.000231	CcSEcCtD
Leflunomide—Rash—Betamethasone—atopic dermatitis	0.000114	0.000229	CcSEcCtD
Leflunomide—Rash—Dexamethasone—atopic dermatitis	0.000114	0.000229	CcSEcCtD
Leflunomide—Dermatitis—Dexamethasone—atopic dermatitis	0.000114	0.000228	CcSEcCtD
Leflunomide—Dermatitis—Betamethasone—atopic dermatitis	0.000114	0.000228	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—KIF3A—atopic dermatitis	0.000114	0.00246	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CASP1—atopic dermatitis	0.000113	0.00245	CbGpPWpGaD
Leflunomide—Headache—Dexamethasone—atopic dermatitis	0.000113	0.000227	CcSEcCtD
Leflunomide—Headache—Betamethasone—atopic dermatitis	0.000113	0.000227	CcSEcCtD
Leflunomide—Asthenia—Prednisone—atopic dermatitis	0.000113	0.000227	CcSEcCtD
Leflunomide—Pruritus—Prednisone—atopic dermatitis	0.000112	0.000223	CcSEcCtD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000108	0.00234	CbGpPWpGaD
Leflunomide—Diarrhoea—Prednisone—atopic dermatitis	0.000108	0.000216	CcSEcCtD
Leflunomide—Nausea—Betamethasone—atopic dermatitis	0.000108	0.000215	CcSEcCtD
Leflunomide—Nausea—Dexamethasone—atopic dermatitis	0.000108	0.000215	CcSEcCtD
Leflunomide—PTK2B—Immune System—IL5—atopic dermatitis	0.000108	0.00233	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	0.000108	0.00233	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	0.000107	0.00232	CbGpPWpGaD
Leflunomide—Dizziness—Prednisone—atopic dermatitis	0.000104	0.000209	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—CMA1—atopic dermatitis	0.000103	0.00223	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCL11—atopic dermatitis	0.000103	0.00223	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—TLR2—atopic dermatitis	0.000103	0.00222	CbGpPWpGaD
Leflunomide—Vomiting—Prednisone—atopic dermatitis	0.0001	0.000201	CcSEcCtD
Leflunomide—Rash—Prednisone—atopic dermatitis	9.95e-05	0.000199	CcSEcCtD
Leflunomide—Dermatitis—Prednisone—atopic dermatitis	9.94e-05	0.000199	CcSEcCtD
Leflunomide—Headache—Prednisone—atopic dermatitis	9.88e-05	0.000198	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—STAT6—atopic dermatitis	9.68e-05	0.00209	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD79A—atopic dermatitis	9.65e-05	0.00209	CbGpPWpGaD
Leflunomide—Nausea—Prednisone—atopic dermatitis	9.37e-05	0.000188	CcSEcCtD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	8.57e-05	0.00185	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCR3—atopic dermatitis	8.39e-05	0.00182	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL18—atopic dermatitis	7.9e-05	0.00171	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	7.8e-05	0.00169	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	7.8e-05	0.00169	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD8A—atopic dermatitis	7.78e-05	0.00168	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GLB1—atopic dermatitis	7.55e-05	0.00163	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TAC1—atopic dermatitis	7.48e-05	0.00162	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NPS—atopic dermatitis	7.48e-05	0.00162	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL6—atopic dermatitis	7.4e-05	0.0016	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CXCR3—atopic dermatitis	7.34e-05	0.00159	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	7.32e-05	0.00158	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ADSL—atopic dermatitis	7.24e-05	0.00157	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL5—atopic dermatitis	6.96e-05	0.0015	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—NFKBIA—atopic dermatitis	6.03e-05	0.0013	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CXCL10—atopic dermatitis	5.93e-05	0.00128	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CASP8—atopic dermatitis	5.44e-05	0.00118	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	5.23e-05	0.00113	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCL5—atopic dermatitis	5.11e-05	0.0011	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NGF—atopic dermatitis	4.73e-05	0.00102	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IFNG—atopic dermatitis	4.63e-05	0.001	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCR5—atopic dermatitis	4.6e-05	0.000995	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD4—atopic dermatitis	4.47e-05	0.000966	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL1B—atopic dermatitis	4.13e-05	0.000892	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL2—atopic dermatitis	4.11e-05	0.000889	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NFKBIA—atopic dermatitis	3.9e-05	0.000843	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GLB1—atopic dermatitis	3.82e-05	0.000825	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—MAPK8—atopic dermatitis	3.78e-05	0.000818	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ADSL—atopic dermatitis	3.66e-05	0.000791	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GLB1—atopic dermatitis	3.26e-05	0.000705	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ADSL—atopic dermatitis	3.13e-05	0.000676	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CXCL8—atopic dermatitis	2.78e-05	0.000601	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.78e-05	0.000601	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL2—atopic dermatitis	2.66e-05	0.000575	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PPARA—atopic dermatitis	2.45e-05	0.00053	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MAPK8—atopic dermatitis	2.45e-05	0.000529	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6—atopic dermatitis	2.42e-05	0.000523	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.38e-05	0.000514	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6—atopic dermatitis	1.56e-05	0.000338	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PPARA—atopic dermatitis	1.24e-05	0.000268	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PPARA—atopic dermatitis	1.06e-05	0.000229	CbGpPWpGaD
